• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国慢性肾脏病患者贫血相关生物标志物与腹膜透析充分性的关联

Association between anemia-related biomarkers and the adequacy of peritoneal dialysis in Chinese patients with chronic kidney disease.

作者信息

Li Jia-Lin, Cai Zhen, Zhao Jing, Zhu Xiang-Gang, Li Qian, Li Yan-Shuang, Liu Meng-Chao, Cui Fang-Qiang, Zhao Wen-Jing, Niu Wen-Quan

机构信息

Department of Nephropathy, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.

Center for Evidence-Based Medicine, Capital Institute of Pediatrics, Beijing, China.

出版信息

Front Physiol. 2023 Jul 27;14:1170537. doi: 10.3389/fphys.2023.1170537. eCollection 2023.

DOI:10.3389/fphys.2023.1170537
PMID:37576337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10413279/
Abstract

The study aimed to examine the association of three anemia-related biomarkers with the adequacy of peritoneal dialysis (PD) in patients with chronic kidney disease (CKD). This study included 127 PD patients. The total Kt/V urea (Kt/V) was calculated according to the Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines. All patients were classified into two groups based on Kt/V, viz., adequate (Kt/V ≥1.7) and inadequate (Kt/V <1.7) groups. Effect sizes are expressed as odds ratios (ORs) and 95% confidence interval (CI). After adjusting for age, gender, hypertension, diabetes, and PD duration, 20 g/L increment in hemoglobin (Hgb) was observed to significantly reduce the risk of inadequate PD by 19% (OR; 95% CI; P: 0.81; 0.70 to 0.95; 0.009), 5 g/L increment in the mean corpuscular hemoglobin concentration (MCHC) by 7% (0.93; 0.88 to 0.98; 0.009), and 5% increment in transferrin saturation (TS) by 23% (0.77; 0.64 to 0.94; 0.012). The gender-specific nomogram model was constructed by incorporating three significant anemia-related biomarkers and convenient influencing factors, and the prediction accuracy was good (concordance index (C-index): 0.686 for men and 0.825 for women). Our findings indicate that the deterioration of three anemia-related biomarkers (Hgb, MCHC, and TS) can precipitate the development of inadequate PD in Chinese patients with CKD.

摘要

该研究旨在探讨三种贫血相关生物标志物与慢性肾脏病(CKD)患者腹膜透析(PD)充分性之间的关联。本研究纳入了127例PD患者。根据肾脏病预后质量倡议(K/DOQI)指南计算总尿素清除率(Kt/V)。所有患者根据Kt/V分为两组,即充分组(Kt/V≥1.7)和不充分组(Kt/V<1.7)。效应大小以比值比(OR)和95%置信区间(CI)表示。在调整年龄、性别、高血压、糖尿病和PD时长后,观察到血红蛋白(Hgb)每增加20 g/L可使PD不充分风险显著降低19%(OR;95%CI;P:0.81;0.70至0.95;0.009),平均红细胞血红蛋白浓度(MCHC)每增加5 g/L可使风险降低7%(0.93;0.88至0.98;0.009),转铁蛋白饱和度(TS)每增加5%可使风险降低23%(0.77;0.64至0.94;0.012)。通过纳入三种重要的贫血相关生物标志物和便捷的影响因素构建了性别特异性列线图模型,预测准确性良好(一致性指数(C指数):男性为0.686,女性为0.825)。我们的研究结果表明,三种贫血相关生物标志物(Hgb、MCHC和TS)的恶化可促使中国CKD患者发生PD不充分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/10413279/1efe298cd4f1/fphys-14-1170537-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/10413279/9234409f12d3/fphys-14-1170537-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/10413279/1efe298cd4f1/fphys-14-1170537-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/10413279/9234409f12d3/fphys-14-1170537-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafc/10413279/1efe298cd4f1/fphys-14-1170537-g002.jpg

相似文献

1
Association between anemia-related biomarkers and the adequacy of peritoneal dialysis in Chinese patients with chronic kidney disease.中国慢性肾脏病患者贫血相关生物标志物与腹膜透析充分性的关联
Front Physiol. 2023 Jul 27;14:1170537. doi: 10.3389/fphys.2023.1170537. eCollection 2023.
2
Relationship between Kt/V urea-based dialysis adequacy and nutritional status and their effect on the components of the quality of life in incident peritoneal dialysis patients.基于 Kt/V 尿素的透析充分性与营养状况之间的关系及其对新进入腹膜透析患者生活质量各组分的影响。
BMC Nephrol. 2012 Jun 14;13:39. doi: 10.1186/1471-2369-13-39.
3
Cycler adequacy and prescription data in a national cohort sample: the 1997 core indicators report. Health Care Financing Administration Peritoneal Dialysis Core Indicators Study Group.全国队列样本中的循环器充分性和处方数据:1997年核心指标报告。医疗保健财务管理局腹膜透析核心指标研究小组。
Kidney Int. 1999 May;55(5):2030-9. doi: 10.1046/j.1523-1755.1999.00447.x.
4
[The effect of the number of peritonitis episodes on peritoneal membrane function].[腹膜炎发作次数对腹膜功能的影响]
Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):28-31.
5
The anemia in continuous ambulatory peritoneal dialysis patients is related to Kt/V index.持续性非卧床腹膜透析患者的贫血与Kt/V指数有关。
Artif Organs. 1999 Jan;23(1):65-9. doi: 10.1046/j.1525-1594.1999.06221.x.
6
Gender-specific differences in dialysis quality (Kt/V): 'big men' are at risk of inadequate haemodialysis treatment.透析质量(Kt/V)的性别差异:“体型高大的男性”存在血液透析治疗不足的风险。
Nephrol Dial Transplant. 1999 Jan;14(1):147-53. doi: 10.1093/ndt/14.1.147.
7
The relationship between Kt/V(urea) and nPNA in anuric peritoneal dialysis patients: a comparison with predialysis patients.无尿腹膜透析患者的尿素清除指数(Kt/V)与标准化蛋白氮出现率(nPNA)之间的关系:与透析前患者的比较
Perit Dial Int. 2001 Sep-Oct;21(5):509-15.
8
Serum concentration of haptoglobin, adequacy of peritoneal dialysis, and nutrition status of patients with and without diabetes on peritoneal dialysis.接受和未接受腹膜透析的糖尿病患者的血清触珠蛋白浓度、腹膜透析充分性及营养状况
Adv Perit Dial. 2003;19:246-50.
9
Retrospective evaluation of renal kt/V(urea) at the initiation of long-term peritoneal dialysis at the University of Missouri: relationships to longitudinal nutritional status on peritoneal dialysis.密苏里大学对长期腹膜透析开始时肾尿素清除率(kt/V)的回顾性评估:与腹膜透析纵向营养状况的关系
ASAIO J. 2003 Jan-Feb;49(1):91-102. doi: 10.1097/00002480-200301000-00015.
10
Influence of residual renal function on dietary protein and caloric intake in patients on incremental peritoneal dialysis.残余肾功能对接受递增式腹膜透析患者饮食蛋白质和热量摄入的影响。
Perit Dial Int. 1999 Jul-Aug;19(4):350-6.

引用本文的文献

1
The Efficacy and Safety of a Personalized Protocol Designed to Balance Hemoglobin Levels in Hemodialysis Patients as Led by Nephrology Clinical Nurse Specialists: An Intervention Study.由肾脏病临床护理专家主导的旨在平衡血液透析患者血红蛋白水平的个性化方案的疗效与安全性:一项干预性研究。
Healthcare (Basel). 2025 Jun 2;13(11):1317. doi: 10.3390/healthcare13111317.

本文引用的文献

1
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
2
Kt/V reach rate is associated with clinical outcome in incident peritoneal dialysis patients.Kt/V 达标率与新进入腹膜透析患者的临床结局相关。
Ren Fail. 2022 Dec;44(1):482-489. doi: 10.1080/0886022X.2022.2048854.
3
Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.全球终末期肾病的流行病学和肾脏替代治疗的差异。
Am J Nephrol. 2021;52(2):98-107. doi: 10.1159/000514550. Epub 2021 Mar 22.
4
Estimation of Prevalence of Kidney Disease Treated With Dialysis in China: A Study of Insurance Claims Data.中国透析治疗的肾脏病患病率估计:一项基于保险理赔数据的研究。
Am J Kidney Dis. 2021 Jun;77(6):889-897.e1. doi: 10.1053/j.ajkd.2020.11.021. Epub 2021 Jan 7.
5
Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report.中国肾脏病网络(CK-NET)2016 年度数据报告摘要。
Kidney Int. 2020 Dec;98(6):1419-1423. doi: 10.1016/j.kint.2020.09.003.
6
The current and future landscape of dialysis.当前和未来的透析领域。
Nat Rev Nephrol. 2020 Oct;16(10):573-585. doi: 10.1038/s41581-020-0315-4. Epub 2020 Jul 30.
7
CKD in China: Evolving Spectrum and Public Health Implications.中国的慢性肾脏病:不断变化的疾病谱与公共卫生影响。
Am J Kidney Dis. 2020 Aug;76(2):258-264. doi: 10.1053/j.ajkd.2019.05.032. Epub 2019 Sep 3.
8
Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.在慢性透析患者中,铁调素和糖尿病与可溶性转铁蛋白受体水平独立相关。
Ren Fail. 2019 Nov;41(1):662-672. doi: 10.1080/0886022X.2019.1635893.
9
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.透析起始、方式选择、通路和处方:肾脏病:改善全球预后组织(KDIGO)争议会议的结论。
Kidney Int. 2019 Jul;96(1):37-47. doi: 10.1016/j.kint.2019.01.017. Epub 2019 Apr 13.
10
Iron Deficiency Anemia in Chronic Kidney Disease.慢性肾脏病中的缺铁性贫血。
Acta Haematol. 2019;142(1):44-50. doi: 10.1159/000496492. Epub 2019 Apr 10.